Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection

H Nakamura, S Fujishima, T Inoue, Y Ohkubo, K Soejima, Y Waki, M Mori, T Urano, F Sakamaki, S Tasaka, A Ishizaka, M Kanazawa, K Yamaguchi
European Respiratory Journal 1999 13: 1371-1379; DOI:
H Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Fujishima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Inoue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y Ohkubo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Soejima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y Waki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Mori
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Urano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Sakamaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Tasaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Ishizaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Kanazawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Yamaguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The clinical and immunoregulatory effects of long-term macrolide antibiotic therapy for patients with chronic lower respiratory tract infections (CLRTI) were investigated. Clinical parameters and neutrophil chemotactic mediators in the epithelial lining fluid (ELF) of CLRTI patients (n = 10) were examined before and after 3 months oral administration of roxithromycin (RXM). The in vitro effects of RXM were also examined on the release of these mediators from alveolar macrophages (AM) and neutrophils. Arterial oxygen tension (p<0.05), vital capacity (VC) (p<0.001), %VC (p<0.05) and forced expiratory volume in one second (p<0.01) were improved after RXM treatment, but airway bacteria were not eradicated. Among the mediators, the levels of interleukin (IL)-8, neutrophil elastase (NE) and leukotriene B4 (LTB4) were higher in ELF than in plasma of CLRTI patients and they decreased after RXM treatment (n = 7, p<0.05 for each). RXM concentrations were significantly increased in the bronchoalveolar lavage cells of the treated patients. In in vitro experiments, RXM showed inhibitory effects on IL-8 release from AM and neutrophils. In conclusion, interleukin-8, neutrophil elastase and leukotriene B4 contribute to the neutrophilic inflammation in the airways of chronic lower respiratory tract infection patients and the clinical effects of roxithromycin may, in part, be attributable to the suppression of excess release of the chemotactic mediators from inflammatory cells.

PreviousNext
Back to top
Vol 13 Issue 6 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
H Nakamura, S Fujishima, T Inoue, Y Ohkubo, K Soejima, Y Waki, M Mori, T Urano, F Sakamaki, S Tasaka, A Ishizaka, M Kanazawa, K Yamaguchi
European Respiratory Journal Jun 1999, 13 (6) 1371-1379;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
H Nakamura, S Fujishima, T Inoue, Y Ohkubo, K Soejima, Y Waki, M Mori, T Urano, F Sakamaki, S Tasaka, A Ishizaka, M Kanazawa, K Yamaguchi
European Respiratory Journal Jun 1999, 13 (6) 1371-1379;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Ambulatory management of secondary spontaneous pneumothorax
  • Systematic assessment of respiratory health in illness susceptible athletes
  • Identifying early PAH biomarkers in systemic sclerosis
Show more Original Articles

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society